Viewing Study NCT00588094

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-04-13 @ 5:03 AM
Study NCT ID: NCT00588094
Status: COMPLETED
Last Update Posted: 2015-12-04
First Post: 2007-12-26
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None B-cell Non-Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None ASCT View
None B-cell non-Hodgkin's lymphoma View
None Cancer View
None Second line therapy View
None ICE View
None Stem cell transplant View